Advertisement
Screener

INMUNE BIO INC. (INMB) Fair Value Adjustment of Warrants

1.8 / 5 stars · 17/46 Roast Me

INMUNE BIO INC. Fair Value Adjustment of Warrants

INMUNE BIO INC. (INMB) reported Fair Value Adjustment of Warrants of $95.00 million for the 1-month period ending 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-03-30

  • 2025-12-31: Fair Value Adjustment of Warrants 1 month $95.00M.
  • 2024-09-30: Fair Value Adjustment of Warrants $9.10M.
  • 2024-04-30: Fair Value Adjustment of Warrants $5.80M; Fair Value Adjustment of Warrants as first filed $3.00M.
  • 2020-07-31: Fair Value Adjustment of Warrants 1 month $356.87K.
Period endFair Value Adjustment of WarrantsFair Value Adjustment of Warrants as first filedFair Value Adjustment of Warrants 1 month
2025-12-31$95.00M
10-K · filed 2026-03-30
2024-09-30$9.10M
10-K · filed 2025-03-27
2024-04-30$5.80M
10-Q · filed 2025-10-30
$3.00M
10-Q · filed 2024-08-01
2020-07-31$356.87K
10-K · filed 2022-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
Tevogen Inc. (TVGN)United States$0.049B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioStem Technologies, Inc. (BSEM)United States$0.069B